

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | tricarboxylic acid cycle (GO:0006099) | 5.14998678 |
| 2 | lysine metabolic process (GO:0006553) | 5.12827350 |
| 3 | lysine catabolic process (GO:0006554) | 5.12827350 |
| 4 | carnitine shuttle (GO:0006853) | 5.02053593 |
| 5 | sarcomere organization (GO:0045214) | 4.78939683 |
| 6 | 2-oxoglutarate metabolic process (GO:0006103) | 4.75615948 |
| 7 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.73058360 |
| 8 | skeletal muscle contraction (GO:0003009) | 4.70433957 |
| 9 | fatty acid transmembrane transport (GO:1902001) | 4.67878865 |
| 10 | aspartate family amino acid catabolic process (GO:0009068) | 4.64677258 |
| 11 | fatty acid beta-oxidation (GO:0006635) | 4.25435115 |
| 12 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.22692939 |
| 13 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.21582593 |
| 14 | cardiac myofibril assembly (GO:0055003) | 4.19855911 |
| 15 | actin filament-based movement (GO:0030048) | 4.15573227 |
| 16 | carnitine transmembrane transport (GO:1902603) | 4.13742229 |
| 17 | carnitine transport (GO:0015879) | 4.13582168 |
| 18 | amino-acid betaine transport (GO:0015838) | 4.13582168 |
| 19 | actin-myosin filament sliding (GO:0033275) | 4.12267352 |
| 20 | muscle filament sliding (GO:0030049) | 4.12267352 |
| 21 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.05787087 |
| 22 | NADH metabolic process (GO:0006734) | 4.03465476 |
| 23 | myofibril assembly (GO:0030239) | 4.01563945 |
| 24 | regulation of skeletal muscle contraction (GO:0014819) | 3.98785212 |
| 25 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.94516136 |
| 26 | short-chain fatty acid metabolic process (GO:0046459) | 3.91177249 |
| 27 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.85825916 |
| 28 | cardiac muscle contraction (GO:0060048) | 3.82793297 |
| 29 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.82382386 |
| 30 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.81714416 |
| 31 | glyoxylate metabolic process (GO:0046487) | 3.79740878 |
| 32 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.79376265 |
| 33 | fatty acid catabolic process (GO:0009062) | 3.76025723 |
| 34 | plasma membrane repair (GO:0001778) | 3.75848946 |
| 35 | tricarboxylic acid metabolic process (GO:0072350) | 3.75600380 |
| 36 | fatty acid oxidation (GO:0019395) | 3.73505326 |
| 37 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.73424844 |
| 38 | L-phenylalanine catabolic process (GO:0006559) | 3.73424844 |
| 39 | acetyl-CoA metabolic process (GO:0006084) | 3.71514090 |
| 40 | cellular ketone body metabolic process (GO:0046950) | 3.71495516 |
| 41 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.70609317 |
| 42 | L-phenylalanine metabolic process (GO:0006558) | 3.70609317 |
| 43 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.69987149 |
| 44 | lipid oxidation (GO:0034440) | 3.68312395 |
| 45 | succinate metabolic process (GO:0006105) | 3.66191269 |
| 46 | regulation of sequestering of triglyceride (GO:0010889) | 3.64611012 |
| 47 | synaptic vesicle maturation (GO:0016188) | 3.63934101 |
| 48 | alpha-linolenic acid metabolic process (GO:0036109) | 3.62632185 |
| 49 | muscle contraction (GO:0006936) | 3.61088653 |
| 50 | synaptic vesicle exocytosis (GO:0016079) | 3.60751374 |
| 51 | regulation of fatty acid oxidation (GO:0046320) | 3.60000262 |
| 52 | neuronal action potential propagation (GO:0019227) | 3.59846887 |
| 53 | branched-chain amino acid catabolic process (GO:0009083) | 3.58477200 |
| 54 | quaternary ammonium group transport (GO:0015697) | 3.57084138 |
| 55 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.55760606 |
| 56 | amino-acid betaine metabolic process (GO:0006577) | 3.52978708 |
| 57 | carnitine metabolic process (GO:0009437) | 3.52905906 |
| 58 | positive regulation of synapse maturation (GO:0090129) | 3.50458139 |
| 59 | creatine metabolic process (GO:0006600) | 3.48486551 |
| 60 | valine metabolic process (GO:0006573) | 3.48250292 |
| 61 | regulation of actin filament-based movement (GO:1903115) | 3.46424955 |
| 62 | monocarboxylic acid catabolic process (GO:0072329) | 3.46190610 |
| 63 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.45513921 |
| 64 | oxaloacetate metabolic process (GO:0006107) | 3.44942486 |
| 65 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.44142040 |
| 66 | cellular potassium ion homeostasis (GO:0030007) | 3.43753370 |
| 67 | branched-chain amino acid metabolic process (GO:0009081) | 3.43150458 |
| 68 | sodium ion export (GO:0071436) | 3.42527174 |
| 69 | kynurenine metabolic process (GO:0070189) | 3.38166762 |
| 70 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.37149068 |
| 71 | biotin metabolic process (GO:0006768) | 3.36833017 |
| 72 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.36331156 |
| 73 | actin-mediated cell contraction (GO:0070252) | 3.35161745 |
| 74 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.34822414 |
| 75 | glutamate secretion (GO:0014047) | 3.31442483 |
| 76 | * regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.30100557 |
| 77 | gluconeogenesis (GO:0006094) | 3.30026009 |
| 78 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.28331646 |
| 79 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.28000143 |
| 80 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.28000143 |
| 81 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.27354124 |
| 82 | striated muscle contraction (GO:0006941) | 3.27037953 |
| 83 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.22767880 |
| 84 | skeletal muscle fiber development (GO:0048741) | 3.22680347 |
| 85 | muscle system process (GO:0003012) | 3.22501686 |
| 86 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.21965583 |
| 87 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.21965583 |
| 88 | positive regulation of fatty acid oxidation (GO:0046321) | 3.19605668 |
| 89 | ketone body metabolic process (GO:1902224) | 3.17016056 |
| 90 | cell communication involved in cardiac conduction (GO:0086065) | 3.16374184 |
| 91 | aromatic amino acid family catabolic process (GO:0009074) | 3.14990741 |
| 92 | regulation of triglyceride catabolic process (GO:0010896) | 3.14833257 |
| 93 | glycogen catabolic process (GO:0005980) | 3.13380212 |
| 94 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.12909191 |
| 95 | response to mercury ion (GO:0046689) | 3.10831500 |
| 96 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.10402336 |
| 97 | response to muscle activity (GO:0014850) | 3.10294015 |
| 98 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.09731803 |
| 99 | cell communication by electrical coupling (GO:0010644) | 3.08631128 |
| 100 | negative regulation of protein localization to cell surface (GO:2000009) | 3.07343052 |
| 101 | dicarboxylic acid catabolic process (GO:0043649) | 3.06405468 |
| 102 | actomyosin structure organization (GO:0031032) | 3.06400972 |
| 103 | ethanol oxidation (GO:0006069) | 3.05910795 |
| 104 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.05373315 |
| 105 | cysteine metabolic process (GO:0006534) | 3.02290375 |
| 106 | skeletal muscle adaptation (GO:0043501) | 3.02108421 |
| 107 | regulation of relaxation of muscle (GO:1901077) | 3.01279991 |
| 108 | glucan catabolic process (GO:0009251) | 2.99099792 |
| 109 | regulation of membrane repolarization (GO:0060306) | 2.99087902 |
| 110 | regulation of synaptic vesicle transport (GO:1902803) | 2.99078112 |
| 111 | detection of calcium ion (GO:0005513) | 2.97683227 |
| 112 | cardiac muscle cell development (GO:0055013) | 2.97525670 |
| 113 | cardiac muscle hypertrophy (GO:0003300) | 2.96588975 |
| 114 | glutamate metabolic process (GO:0006536) | 2.96157283 |
| 115 | * regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.95974218 |
| 116 | heart process (GO:0003015) | 2.95277826 |
| 117 | heart contraction (GO:0060047) | 2.95277826 |
| 118 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.95146217 |
| 119 | hexose biosynthetic process (GO:0019319) | 2.94675649 |
| 120 | alpha-amino acid catabolic process (GO:1901606) | 2.94602165 |
| 121 | regulation of cell communication by electrical coupling (GO:0010649) | 2.94538948 |
| 122 | cellular modified amino acid catabolic process (GO:0042219) | 2.92624381 |
| 123 | carboxylic acid catabolic process (GO:0046395) | 2.91255649 |
| 124 | organic acid catabolic process (GO:0016054) | 2.91255649 |
| 125 | fructose metabolic process (GO:0006000) | 2.90786287 |
| 126 | cellular amino acid catabolic process (GO:0009063) | 2.89709514 |
| 127 | adult heart development (GO:0007512) | 2.89619417 |
| 128 | sulfur amino acid catabolic process (GO:0000098) | 2.89167636 |
| 129 | response to inactivity (GO:0014854) | 2.87388404 |
| 130 | muscle hypertrophy (GO:0014896) | 2.86966584 |
| 131 | activation of protein kinase A activity (GO:0034199) | 2.86839585 |
| 132 | striated muscle hypertrophy (GO:0014897) | 2.86645957 |
| 133 | myotube cell development (GO:0014904) | 2.85303661 |
| 134 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.84954497 |
| 135 | regulation of synapse maturation (GO:0090128) | 2.84186340 |
| 136 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.83706660 |
| 137 | striated muscle adaptation (GO:0014888) | 2.82449526 |
| 138 | cerebellar granule cell differentiation (GO:0021707) | 2.81871036 |
| 139 | regulation of synapse structural plasticity (GO:0051823) | 2.81024224 |
| 140 | muscle tissue morphogenesis (GO:0060415) | 2.80258962 |
| 141 | regulation of the force of heart contraction (GO:0002026) | 2.79947905 |
| 142 | regulation of striated muscle contraction (GO:0006942) | 2.78685520 |
| 143 | cellular response to epinephrine stimulus (GO:0071872) | 2.78402703 |
| 144 | fatty acid homeostasis (GO:0055089) | 2.78235356 |
| 145 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.77287099 |
| 146 | muscle hypertrophy in response to stress (GO:0003299) | 2.77287099 |
| 147 | cardiac muscle adaptation (GO:0014887) | 2.77287099 |
| 148 | relaxation of muscle (GO:0090075) | 2.76903868 |
| 149 | neuromuscular synaptic transmission (GO:0007274) | 2.76772403 |
| 150 | cellular polysaccharide catabolic process (GO:0044247) | 2.76522295 |
| 151 | cardiac cell development (GO:0055006) | 2.75255810 |
| 152 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.74788127 |
| 153 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.73522347 |
| 154 | postsynaptic membrane organization (GO:0001941) | 2.68206484 |
| 155 | membrane depolarization during action potential (GO:0086010) | 2.67857505 |
| 156 | muscle fiber development (GO:0048747) | 2.66692018 |
| 157 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.66493514 |
| 158 | potassium ion import (GO:0010107) | 2.64664886 |
| 159 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.64220171 |
| 160 | monosaccharide biosynthetic process (GO:0046364) | 2.58927764 |
| 161 | cellular sodium ion homeostasis (GO:0006883) | 2.57878594 |
| 162 | muscle cell cellular homeostasis (GO:0046716) | 2.56981878 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.22938256 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.90461080 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.31383971 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.88116753 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.59534074 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.12239464 |
| 7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.06818261 |
| 8 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.89896074 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.85013237 |
| 10 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.23728343 |
| 11 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.15371389 |
| 12 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.07209277 |
| 13 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.05447888 |
| 14 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.05447888 |
| 15 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.91738290 |
| 16 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.88380016 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.88374398 |
| 18 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.85085861 |
| 19 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.82924854 |
| 20 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.81121087 |
| 21 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.77223238 |
| 22 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.75824959 |
| 23 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.65521927 |
| 24 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.63880169 |
| 25 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.61335959 |
| 26 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.61072544 |
| 27 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.56641697 |
| 28 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.53443995 |
| 29 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.52240551 |
| 30 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.52045168 |
| 31 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.50981386 |
| 32 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.50740818 |
| 33 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.47230958 |
| 34 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.43211021 |
| 35 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.42485365 |
| 36 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.40606016 |
| 37 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.40579377 |
| 38 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.36982506 |
| 39 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.36572100 |
| 40 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.33906031 |
| 41 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.32310734 |
| 42 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30681727 |
| 43 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.28645589 |
| 44 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.28604384 |
| 45 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.23465879 |
| 46 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.22592164 |
| 47 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.22051059 |
| 48 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.20598777 |
| 49 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.19965772 |
| 50 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.18557606 |
| 51 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.17959369 |
| 52 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.17205164 |
| 53 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.16416904 |
| 54 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.15583956 |
| 55 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.15395372 |
| 56 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.15117142 |
| 57 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.15018271 |
| 58 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.13701481 |
| 59 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.08665083 |
| 60 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.08575994 |
| 61 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.06786693 |
| 62 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.06722585 |
| 63 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.06566370 |
| 64 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.06481345 |
| 65 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.04912511 |
| 66 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.03204071 |
| 67 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02885426 |
| 68 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.02335728 |
| 69 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.01057877 |
| 70 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.00513056 |
| 71 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.00314279 |
| 72 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.99597440 |
| 73 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.99330010 |
| 74 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.99299987 |
| 75 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.99079230 |
| 76 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.98172137 |
| 77 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.97622507 |
| 78 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.97622507 |
| 79 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.97484592 |
| 80 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.97157032 |
| 81 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.96857623 |
| 82 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.94715369 |
| 83 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.94248849 |
| 84 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.94058947 |
| 85 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.93419838 |
| 86 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.93257955 |
| 87 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93124829 |
| 88 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.92822592 |
| 89 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92682772 |
| 90 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.92355803 |
| 91 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.92201486 |
| 92 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.92079685 |
| 93 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.90976136 |
| 94 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.89633072 |
| 95 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.89086625 |
| 96 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.88542666 |
| 97 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.88251944 |
| 98 | P68_20966046_ChIP-Seq_HELA_Human | 0.87452088 |
| 99 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.86028595 |
| 100 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.85720826 |
| 101 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.83933406 |
| 102 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.83218317 |
| 103 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.83093198 |
| 104 | KDM2B_26808549_Chip-Seq_K562_Human | 0.82866393 |
| 105 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.82050156 |
| 106 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.81093477 |
| 107 | GATA1_22025678_ChIP-Seq_K562_Human | 0.80538579 |
| 108 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.80514699 |
| 109 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80273913 |
| 110 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80120409 |
| 111 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.79731759 |
| 112 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.77986945 |
| 113 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.77497959 |
| 114 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.77355239 |
| 115 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.77281222 |
| 116 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.77182987 |
| 117 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.76839790 |
| 118 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.76823712 |
| 119 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.75331448 |
| 120 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.74586557 |
| 121 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.74163113 |
| 122 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73992451 |
| 123 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.73832106 |
| 124 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.73731776 |
| 125 | GATA2_19941826_ChIP-Seq_K562_Human | 0.73720293 |
| 126 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.73424721 |
| 127 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.72627873 |
| 128 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.71894442 |
| 129 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.71889712 |
| 130 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.71835546 |
| 131 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.71317475 |
| 132 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.70827811 |
| 133 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.70518389 |
| 134 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.70483958 |
| 135 | SA1_27219007_Chip-Seq_Bcells_Human | 0.69445634 |
| 136 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.67769360 |
| 137 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.66204178 |
| 138 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.65614363 |
| 139 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.64974741 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.38823335 |
| 2 | MP0003646_muscle_fatigue | 4.91606862 |
| 3 | MP0000751_myopathy | 4.01714175 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.59695577 |
| 5 | MP0005360_urolithiasis | 3.51019345 |
| 6 | MP0004084_abnormal_cardiac_muscle | 3.46581900 |
| 7 | MP0004036_abnormal_muscle_relaxation | 3.22971731 |
| 8 | MP0004215_abnormal_myocardial_fiber | 3.17781436 |
| 9 | MP0000749_muscle_degeneration | 3.13648439 |
| 10 | MP0004270_analgesia | 2.94831242 |
| 11 | MP0004130_abnormal_muscle_cell | 2.84257736 |
| 12 | MP0005085_abnormal_gallbladder_physiolo | 2.81975939 |
| 13 | MP0005365_abnormal_bile_salt | 2.79025322 |
| 14 | MP0005330_cardiomyopathy | 2.71552448 |
| 15 | MP0005423_abnormal_somatic_nervous | 2.49299261 |
| 16 | MP0004087_abnormal_muscle_fiber | 2.37286777 |
| 17 | MP0004145_abnormal_muscle_electrophysio | 2.30233679 |
| 18 | MP0008875_abnormal_xenobiotic_pharmacok | 2.25196008 |
| 19 | MP0003806_abnormal_nucleotide_metabolis | 2.15507500 |
| 20 | MP0005620_abnormal_muscle_contractility | 2.14304093 |
| 21 | MP0002972_abnormal_cardiac_muscle | 2.11087409 |
| 22 | MP0002269_muscular_atrophy | 2.09954522 |
| 23 | MP0000747_muscle_weakness | 2.04813679 |
| 24 | MP0003879_abnormal_hair_cell | 2.04228080 |
| 25 | MP0005670_abnormal_white_adipose | 1.99864432 |
| 26 | MP0005332_abnormal_amino_acid | 1.98878268 |
| 27 | MP0003880_abnormal_central_pattern | 1.98549041 |
| 28 | MP0006036_abnormal_mitochondrial_physio | 1.98004585 |
| 29 | MP0003137_abnormal_impulse_conducting | 1.95831009 |
| 30 | MP0002106_abnormal_muscle_physiology | 1.93625525 |
| 31 | MP0003635_abnormal_synaptic_transmissio | 1.85576438 |
| 32 | MP0010329_abnormal_lipoprotein_level | 1.85334068 |
| 33 | MP0000750_abnormal_muscle_regeneration | 1.84202987 |
| 34 | MP0008775_abnormal_heart_ventricle | 1.79697602 |
| 35 | MP0004043_abnormal_pH_regulation | 1.78005366 |
| 36 | MP0005666_abnormal_adipose_tissue | 1.76229967 |
| 37 | MP0005385_cardiovascular_system_phenoty | 1.75449853 |
| 38 | MP0001544_abnormal_cardiovascular_syste | 1.75449853 |
| 39 | MP0003195_calcinosis | 1.75314360 |
| 40 | MP0003252_abnormal_bile_duct | 1.72894433 |
| 41 | MP0002064_seizures | 1.71962614 |
| 42 | MP0009840_abnormal_foam_cell | 1.68917437 |
| 43 | MP0006138_congestive_heart_failure | 1.68389782 |
| 44 | MP0005083_abnormal_biliary_tract | 1.65856771 |
| 45 | MP0010630_abnormal_cardiac_muscle | 1.65792242 |
| 46 | MP0000759_abnormal_skeletal_muscle | 1.63511259 |
| 47 | MP0004484_altered_response_of | 1.59274710 |
| 48 | MP0005369_muscle_phenotype | 1.58253687 |
| 49 | MP0004233_abnormal_muscle_weight | 1.49787908 |
| 50 | MP0002118_abnormal_lipid_homeostasis | 1.46389619 |
| 51 | MP0004085_abnormal_heartbeat | 1.42816109 |
| 52 | MP0009745_abnormal_behavioral_response | 1.41710106 |
| 53 | MP0002734_abnormal_mechanical_nocicepti | 1.40261870 |
| 54 | MP0002063_abnormal_learning/memory/cond | 1.39977602 |
| 55 | MP0002272_abnormal_nervous_system | 1.38627860 |
| 56 | MP0005319_abnormal_enzyme/_coenzyme | 1.28901226 |
| 57 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.27020429 |
| 58 | MP0002332_abnormal_exercise_endurance | 1.25594286 |
| 59 | MP0002971_abnormal_brown_adipose | 1.20385015 |
| 60 | MP0003221_abnormal_cardiomyocyte_apopto | 1.20168240 |
| 61 | MP0001666_abnormal_nutrient_absorption | 1.17097274 |
| 62 | MP0005375_adipose_tissue_phenotype | 1.16870248 |
| 63 | MP0002572_abnormal_emotion/affect_behav | 1.11896638 |
| 64 | MP0005535_abnormal_body_temperature | 1.09565992 |
| 65 | MP0003329_amyloid_beta_deposits | 1.08871585 |
| 66 | MP0004185_abnormal_adipocyte_glucose | 1.08756940 |
| 67 | MP0003705_abnormal_hypodermis_morpholog | 1.08436805 |
| 68 | MP0006035_abnormal_mitochondrial_morpho | 1.07405761 |
| 69 | MP0001486_abnormal_startle_reflex | 1.06966424 |
| 70 | MP0003191_abnormal_cellular_cholesterol | 1.06129677 |
| 71 | MP0009643_abnormal_urine_homeostasis | 1.05160916 |
| 72 | MP0002909_abnormal_adrenal_gland | 1.00640531 |
| 73 | MP0002078_abnormal_glucose_homeostasis | 1.00184083 |
| 74 | MP0000733_abnormal_muscle_development | 0.99348822 |
| 75 | MP0002822_catalepsy | 0.97936502 |
| 76 | MP0000609_abnormal_liver_physiology | 0.97673652 |
| 77 | MP0000230_abnormal_systemic_arterial | 0.97582052 |
| 78 | MP0008961_abnormal_basal_metabolism | 0.96334932 |
| 79 | MP0006276_abnormal_autonomic_nervous | 0.95924387 |
| 80 | MP0001968_abnormal_touch/_nociception | 0.94309158 |
| 81 | MP0001501_abnormal_sleep_pattern | 0.94260104 |
| 82 | MP0001905_abnormal_dopamine_level | 0.93553346 |
| 83 | MP0005266_abnormal_metabolism | 0.92810484 |
| 84 | MP0002733_abnormal_thermal_nociception | 0.91482236 |
| 85 | MP0001502_abnormal_circadian_rhythm | 0.90079216 |
| 86 | MP0004019_abnormal_vitamin_homeostasis | 0.89307442 |
| 87 | MP0010368_abnormal_lymphatic_system | 0.87792454 |
| 88 | MP0002066_abnormal_motor_capabilities/c | 0.87687238 |
| 89 | MP0009046_muscle_twitch | 0.86726419 |
| 90 | MP0002067_abnormal_sensory_capabilities | 0.85334068 |
| 91 | MP0002127_abnormal_cardiovascular_syste | 0.82877622 |
| 92 | MP0001765_abnormal_ion_homeostasis | 0.81998850 |
| 93 | MP0003828_pulmonary_edema | 0.81997976 |
| 94 | MP0005165_increased_susceptibility_to | 0.81673579 |
| 95 | MP0001970_abnormal_pain_threshold | 0.80778761 |
| 96 | MP0004924_abnormal_behavior | 0.80590121 |
| 97 | MP0005386_behavior/neurological_phenoty | 0.80590121 |
| 98 | MP0009780_abnormal_chondrocyte_physiolo | 0.79727474 |
| 99 | MP0003656_abnormal_erythrocyte_physiolo | 0.79005207 |
| 100 | MP0004147_increased_porphyrin_level | 0.78710801 |
| 101 | MP0001440_abnormal_grooming_behavior | 0.76847267 |
| 102 | MP0000013_abnormal_adipose_tissue | 0.75476276 |
| 103 | MP0005334_abnormal_fat_pad | 0.74857526 |
| 104 | MP0002108_abnormal_muscle_morphology | 0.74395855 |
| 105 | MP0005451_abnormal_body_composition | 0.73544467 |
| 106 | MP0004510_myositis | 0.73362057 |
| 107 | MP0002638_abnormal_pupillary_reflex | 0.73297533 |
| 108 | MP0002249_abnormal_larynx_morphology | 0.73113854 |
| 109 | MP0000920_abnormal_myelination | 0.71231685 |
| 110 | MP0001529_abnormal_vocalization | 0.70376161 |
| 111 | MP0000343_altered_response_to | 0.69900414 |
| 112 | MP0004859_abnormal_synaptic_plasticity | 0.69757345 |
| 113 | MP0010030_abnormal_orbit_morphology | 0.69005147 |
| 114 | MP0005636_abnormal_mineral_homeostasis | 0.67363333 |
| 115 | MP0001984_abnormal_olfaction | 0.66573183 |
| 116 | MP0000003_abnormal_adipose_tissue | 0.66027970 |
| 117 | MP0005166_decreased_susceptibility_to | 0.65757461 |
| 118 | MP0002138_abnormal_hepatobiliary_system | 0.65354004 |
| 119 | MP0003690_abnormal_glial_cell | 0.65061839 |
| 120 | MP0002234_abnormal_pharynx_morphology | 0.62813089 |
| 121 | MP0002736_abnormal_nociception_after | 0.62463809 |
| 122 | MP0000604_amyloidosis | 0.61656660 |
| 123 | MP0002557_abnormal_social/conspecific_i | 0.61272836 |
| 124 | MP0001756_abnormal_urination | 0.60781103 |
| 125 | MP0000266_abnormal_heart_morphology | 0.60173266 |
| 126 | MP0008569_lethality_at_weaning | 0.59844911 |
| 127 | MP0004811_abnormal_neuron_physiology | 0.58689617 |
| 128 | MP0005167_abnormal_blood-brain_barrier | 0.57608718 |
| 129 | MP0001299_abnormal_eye_distance/ | 0.57040901 |
| 130 | MP0005448_abnormal_energy_balance | 0.55952156 |
| 131 | MP0003950_abnormal_plasma_membrane | 0.55438207 |
| 132 | MP0008874_decreased_physiological_sensi | 0.54675833 |
| 133 | MP0003633_abnormal_nervous_system | 0.54207186 |
| 134 | MP0001764_abnormal_homeostasis | 0.51541996 |
| 135 | MP0009642_abnormal_blood_homeostasis | 0.51097665 |
| 136 | MP0003075_altered_response_to | 0.49881402 |
| 137 | MP0003953_abnormal_hormone_level | 0.49655159 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 5.75697324 |
| 2 | Sudden death (HP:0001699) | 5.25954926 |
| 3 | Exercise-induced muscle cramps (HP:0003710) | 5.09451720 |
| 4 | Myoglobinuria (HP:0002913) | 5.04782091 |
| 5 | Calf muscle hypertrophy (HP:0008981) | 4.75642153 |
| 6 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.56480065 |
| 7 | Muscle fiber splitting (HP:0003555) | 4.36701066 |
| 8 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.21853406 |
| 9 | Ventricular tachycardia (HP:0004756) | 4.16738741 |
| 10 | Ketoacidosis (HP:0001993) | 4.03877584 |
| 11 | Hyporeflexia of lower limbs (HP:0002600) | 3.93398436 |
| 12 | Ketosis (HP:0001946) | 3.89711737 |
| 13 | Distal arthrogryposis (HP:0005684) | 3.86730613 |
| 14 | Distal lower limb muscle weakness (HP:0009053) | 3.75948716 |
| 15 | Abnormality of the calf musculature (HP:0001430) | 3.72035196 |
| 16 | Rhabdomyolysis (HP:0003201) | 3.68984675 |
| 17 | Hyperglycinuria (HP:0003108) | 3.68492515 |
| 18 | Round ear (HP:0100830) | 3.57739888 |
| 19 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.56807731 |
| 20 | Hypoglycemic coma (HP:0001325) | 3.55986955 |
| 21 | Atrial fibrillation (HP:0005110) | 3.54556039 |
| 22 | Bundle branch block (HP:0011710) | 3.49818072 |
| 23 | Hyperammonemia (HP:0001987) | 3.38312133 |
| 24 | Difficulty running (HP:0009046) | 3.37006874 |
| 25 | Rimmed vacuoles (HP:0003805) | 3.36992126 |
| 26 | Asymmetric septal hypertrophy (HP:0001670) | 3.36784575 |
| 27 | Right ventricular cardiomyopathy (HP:0011663) | 3.34716561 |
| 28 | Subaortic stenosis (HP:0001682) | 3.32098678 |
| 29 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.32098678 |
| 30 | Myokymia (HP:0002411) | 3.29549903 |
| 31 | Primary atrial arrhythmia (HP:0001692) | 3.28091347 |
| 32 | EMG: myopathic abnormalities (HP:0003458) | 3.27044159 |
| 33 | Abnormality of glycine metabolism (HP:0010895) | 3.26696403 |
| 34 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.26696403 |
| 35 | Lipoatrophy (HP:0100578) | 3.26550576 |
| 36 | Palpitations (HP:0001962) | 3.25074641 |
| 37 | Syncope (HP:0001279) | 3.17251542 |
| 38 | Supraventricular tachycardia (HP:0004755) | 3.13779813 |
| 39 | Ulnar deviation of the wrist (HP:0003049) | 3.10361763 |
| 40 | Increased connective tissue (HP:0009025) | 3.10240921 |
| 41 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.08430985 |
| 42 | Dicarboxylic aciduria (HP:0003215) | 3.08430985 |
| 43 | Gout (HP:0001997) | 3.07563090 |
| 44 | Supraventricular arrhythmia (HP:0005115) | 3.06654451 |
| 45 | Heart block (HP:0012722) | 2.99891550 |
| 46 | Dilated cardiomyopathy (HP:0001644) | 2.99270124 |
| 47 | Myotonia (HP:0002486) | 2.95476846 |
| 48 | Atrioventricular block (HP:0001678) | 2.92564112 |
| 49 | Frequent falls (HP:0002359) | 2.88082933 |
| 50 | Prolonged QT interval (HP:0001657) | 2.83624383 |
| 51 | Muscle stiffness (HP:0003552) | 2.83385309 |
| 52 | Ventricular arrhythmia (HP:0004308) | 2.82421215 |
| 53 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.82064503 |
| 54 | Abnormal atrioventricular conduction (HP:0005150) | 2.78076786 |
| 55 | Ventricular fibrillation (HP:0001663) | 2.75893615 |
| 56 | Muscle fiber inclusion bodies (HP:0100299) | 2.73102756 |
| 57 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.72144061 |
| 58 | Xanthomatosis (HP:0000991) | 2.71998874 |
| 59 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.70033969 |
| 60 | Hyperglycinemia (HP:0002154) | 2.67776753 |
| 61 | Distal lower limb amyotrophy (HP:0008944) | 2.64781778 |
| 62 | Hepatic necrosis (HP:0002605) | 2.58502421 |
| 63 | Abnormality of the foot musculature (HP:0001436) | 2.58259686 |
| 64 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.58181172 |
| 65 | Type 1 muscle fiber predominance (HP:0003803) | 2.55078248 |
| 66 | Foot dorsiflexor weakness (HP:0009027) | 2.52275937 |
| 67 | Deep venous thrombosis (HP:0002625) | 2.52135284 |
| 68 | Bulbar palsy (HP:0001283) | 2.52128144 |
| 69 | Hyperlipoproteinemia (HP:0010980) | 2.51312959 |
| 70 | Generalized aminoaciduria (HP:0002909) | 2.49683696 |
| 71 | Hypoalphalipoproteinemia (HP:0003233) | 2.49267963 |
| 72 | Metabolic acidosis (HP:0001942) | 2.47587336 |
| 73 | Intrahepatic cholestasis (HP:0001406) | 2.47175487 |
| 74 | Cerebral edema (HP:0002181) | 2.45537512 |
| 75 | Increased muscle lipid content (HP:0009058) | 2.45406625 |
| 76 | Cholelithiasis (HP:0001081) | 2.38618848 |
| 77 | Generalized muscle weakness (HP:0003324) | 2.38573520 |
| 78 | Areflexia of lower limbs (HP:0002522) | 2.38241802 |
| 79 | Ankle clonus (HP:0011448) | 2.32350084 |
| 80 | Lower limb amyotrophy (HP:0007210) | 2.30662131 |
| 81 | Calcaneovalgus deformity (HP:0001848) | 2.29035535 |
| 82 | Difficulty climbing stairs (HP:0003551) | 2.28652913 |
| 83 | Focal motor seizures (HP:0011153) | 2.26317989 |
| 84 | Scapular winging (HP:0003691) | 2.25134950 |
| 85 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.24903677 |
| 86 | Absent phalangeal crease (HP:0006109) | 2.24603461 |
| 87 | Abnormal gallbladder morphology (HP:0012437) | 2.24310338 |
| 88 | Gowers sign (HP:0003391) | 2.23348423 |
| 89 | Increased variability in muscle fiber diameter (HP:0003557) | 2.22328249 |
| 90 | Increased purine levels (HP:0004368) | 2.22219680 |
| 91 | Hyperuricemia (HP:0002149) | 2.22219680 |
| 92 | Fetal akinesia sequence (HP:0001989) | 2.22099430 |
| 93 | Acute encephalopathy (HP:0006846) | 2.17861311 |
| 94 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.15478069 |
| 95 | Lethargy (HP:0001254) | 2.14746957 |
| 96 | Abnormality of purine metabolism (HP:0004352) | 2.14274367 |
| 97 | Ragged-red muscle fibers (HP:0003200) | 2.12730231 |
| 98 | Dysmetric saccades (HP:0000641) | 2.11936619 |
| 99 | Spinal rigidity (HP:0003306) | 2.10783866 |
| 100 | Abnormal EKG (HP:0003115) | 2.08834133 |
| 101 | Late onset (HP:0003584) | 2.07985175 |
| 102 | Proximal tubulopathy (HP:0000114) | 2.06456789 |
| 103 | Pheochromocytoma (HP:0002666) | 2.04929471 |
| 104 | Hypolipoproteinemia (HP:0010981) | 2.04386947 |
| 105 | Nemaline bodies (HP:0003798) | 2.04220175 |
| 106 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.03897194 |
| 107 | Deformed tarsal bones (HP:0008119) | 2.03242069 |
| 108 | Malignant hyperthermia (HP:0002047) | 2.02377882 |
| 109 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.00623493 |
| 110 | Vomiting (HP:0002013) | 1.99898310 |
| 111 | Hepatocellular necrosis (HP:0001404) | 1.98108409 |
| 112 | Limb-girdle muscle atrophy (HP:0003797) | 1.96332152 |
| 113 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.94495859 |
| 114 | Weak cry (HP:0001612) | 1.92447562 |
| 115 | Oligomenorrhea (HP:0000876) | 1.92033962 |
| 116 | Delayed CNS myelination (HP:0002188) | 1.90210764 |
| 117 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.89644863 |
| 118 | Lactic acidosis (HP:0003128) | 1.89576181 |
| 119 | Left ventricular hypertrophy (HP:0001712) | 1.87766032 |
| 120 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.86382745 |
| 121 | Conjunctival hamartoma (HP:0100780) | 1.85831734 |
| 122 | Waddling gait (HP:0002515) | 1.85172331 |
| 123 | Increased intramyocellular lipid droplets (HP:0012240) | 1.84347858 |
| 124 | Abnormality of serum amino acid levels (HP:0003112) | 1.82715708 |
| 125 | Slender build (HP:0001533) | 1.79187951 |
| 126 | Skin nodule (HP:0200036) | 1.78908072 |
| 127 | Neck muscle weakness (HP:0000467) | 1.78742442 |
| 128 | EMG: neuropathic changes (HP:0003445) | 1.78451651 |
| 129 | Exercise intolerance (HP:0003546) | 1.77652555 |
| 130 | Myopathic facies (HP:0002058) | 1.77313578 |
| 131 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.76402567 |
| 132 | Acute necrotizing encephalopathy (HP:0006965) | 1.76198267 |
| 133 | Nonprogressive disorder (HP:0003680) | 1.73166310 |
| 134 | Athetosis (HP:0002305) | 1.71531458 |
| 135 | Abnormality of the neuromuscular junction (HP:0003398) | 1.70777215 |
| 136 | Fatigable weakness (HP:0003473) | 1.70777215 |
| 137 | Abnormal eating behavior (HP:0100738) | 1.70707870 |
| 138 | Atonic seizures (HP:0010819) | 1.69144689 |
| 139 | Obstructive sleep apnea (HP:0002870) | 1.68650595 |
| 140 | Abnormal finger flexion creases (HP:0006143) | 1.67451426 |
| 141 | Hip contracture (HP:0003273) | 1.64986034 |
| 142 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.61261497 |
| 143 | Poor eye contact (HP:0000817) | 1.60947831 |
| 144 | Focal seizures (HP:0007359) | 1.60537486 |
| 145 | Tetraplegia (HP:0002445) | 1.58802487 |
| 146 | Neonatal onset (HP:0003623) | 1.56332678 |
| 147 | Diplopia (HP:0000651) | 1.55730260 |
| 148 | Abnormality of binocular vision (HP:0011514) | 1.55730260 |
| 149 | Abnormality of glycolysis (HP:0004366) | 1.55662307 |
| 150 | Increased serum pyruvate (HP:0003542) | 1.55626695 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 4.21830316 |
| 2 | BCKDK | 4.15476714 |
| 3 | PHKG2 | 3.80055745 |
| 4 | PHKG1 | 3.80055745 |
| 5 | OBSCN | 3.38596711 |
| 6 | PDK4 | 3.33895112 |
| 7 | PDK3 | 3.33895112 |
| 8 | LMTK2 | 3.22260594 |
| 9 | TRIB3 | 3.16508235 |
| 10 | MARK1 | 2.66188563 |
| 11 | PINK1 | 2.58062755 |
| 12 | PKN2 | 2.30213636 |
| 13 | LIMK1 | 2.15446316 |
| 14 | MYLK | 2.11157354 |
| 15 | NEK1 | 2.06225186 |
| 16 | PDK2 | 2.05346057 |
| 17 | TESK1 | 1.98923846 |
| 18 | DMPK | 1.96685699 |
| 19 | WNK4 | 1.94619407 |
| 20 | SIK1 | 1.77197488 |
| 21 | RIPK1 | 1.57500817 |
| 22 | MAP3K7 | 1.52612920 |
| 23 | MUSK | 1.52324924 |
| 24 | TIE1 | 1.44652356 |
| 25 | PIK3CA | 1.43018178 |
| 26 | NTRK3 | 1.38752251 |
| 27 | UHMK1 | 1.34778170 |
| 28 | ERN1 | 1.30745904 |
| 29 | MAP2K4 | 1.28942656 |
| 30 | PRKD3 | 1.27132165 |
| 31 | STK38 | 1.24206202 |
| 32 | ARAF | 1.22150790 |
| 33 | DYRK1B | 1.22140531 |
| 34 | TESK2 | 1.21223469 |
| 35 | INSRR | 1.20090543 |
| 36 | MAPK12 | 1.17473111 |
| 37 | NTRK2 | 1.08171749 |
| 38 | PAK3 | 1.07297198 |
| 39 | PRPF4B | 1.05794611 |
| 40 | MARK2 | 1.04702053 |
| 41 | CAMK2B | 1.04496852 |
| 42 | FGFR4 | 0.99020101 |
| 43 | PRKAA1 | 0.98617816 |
| 44 | EPHB1 | 0.98083685 |
| 45 | PRKAA2 | 0.97829727 |
| 46 | GRK5 | 0.96074246 |
| 47 | MAP2K3 | 0.94372773 |
| 48 | PRKD1 | 0.93263287 |
| 49 | SIK2 | 0.92515098 |
| 50 | CDK19 | 0.88283061 |
| 51 | TAOK2 | 0.87475285 |
| 52 | SGK3 | 0.85196328 |
| 53 | CAMK2D | 0.84019216 |
| 54 | ICK | 0.82362566 |
| 55 | PDPK1 | 0.80684425 |
| 56 | WNK1 | 0.79488487 |
| 57 | MAPK13 | 0.79135036 |
| 58 | STK39 | 0.78662430 |
| 59 | NME1 | 0.78503685 |
| 60 | MINK1 | 0.78161870 |
| 61 | CDK5 | 0.77645030 |
| 62 | PIK3CG | 0.75712213 |
| 63 | DAPK2 | 0.74518146 |
| 64 | SGK494 | 0.74371966 |
| 65 | SGK223 | 0.74371966 |
| 66 | MAP3K4 | 0.73692914 |
| 67 | MAPK4 | 0.71347927 |
| 68 | OXSR1 | 0.70839307 |
| 69 | AKT2 | 0.70413145 |
| 70 | PDK1 | 0.68557610 |
| 71 | KSR2 | 0.67231130 |
| 72 | PAK6 | 0.66677331 |
| 73 | ROCK1 | 0.66631775 |
| 74 | PTK6 | 0.66378033 |
| 75 | CAMK1G | 0.66375110 |
| 76 | CAMK4 | 0.66040045 |
| 77 | DAPK1 | 0.63941762 |
| 78 | CCNB1 | 0.63566189 |
| 79 | SGK2 | 0.62426045 |
| 80 | PTK2B | 0.61589874 |
| 81 | PRKCH | 0.61132714 |
| 82 | CAMK1 | 0.60698331 |
| 83 | FLT3 | 0.60635517 |
| 84 | CAMK2G | 0.60634471 |
| 85 | MAPKAPK3 | 0.59873128 |
| 86 | TNK2 | 0.59177073 |
| 87 | EPHA4 | 0.57937523 |
| 88 | STK38L | 0.57678228 |
| 89 | CDK15 | 0.57526506 |
| 90 | CAMK1D | 0.57373915 |
| 91 | TAOK1 | 0.57360470 |
| 92 | NTRK1 | 0.55961957 |
| 93 | CDK11A | 0.55389840 |
| 94 | PRKG2 | 0.54599963 |
| 95 | EPHB2 | 0.54376096 |
| 96 | MAPK11 | 0.54236326 |
| 97 | PRKACG | 0.54083678 |
| 98 | RET | 0.53719289 |
| 99 | STK24 | 0.53636184 |
| 100 | PDGFRA | 0.53185491 |
| 101 | CDK14 | 0.52980656 |
| 102 | CAMKK1 | 0.52867822 |
| 103 | MAP3K5 | 0.52265272 |
| 104 | ILK | 0.51622336 |
| 105 | CDK18 | 0.51548894 |
| 106 | CDC42BPA | 0.51017925 |
| 107 | MAP2K6 | 0.50663191 |
| 108 | PKN1 | 0.50469852 |
| 109 | GRK7 | 0.49955531 |
| 110 | PRKD2 | 0.49430081 |
| 111 | PRKG1 | 0.49327893 |
| 112 | WNK3 | 0.48484810 |
| 113 | MAP3K1 | 0.48056673 |
| 114 | CAMK2A | 0.47714878 |
| 115 | TYRO3 | 0.47338876 |
| 116 | PRKACB | 0.43045923 |
| 117 | DAPK3 | 0.41924100 |
| 118 | MAP3K3 | 0.41314743 |
| 119 | PRKACA | 0.39469542 |
| 120 | NEK9 | 0.39147817 |
| 121 | TGFBR2 | 0.38606832 |
| 122 | JAK2 | 0.37142432 |
| 123 | SGK1 | 0.36905436 |
| 124 | KDR | 0.36857364 |
| 125 | MAPK10 | 0.36581331 |
| 126 | FER | 0.36355016 |
| 127 | MAP3K6 | 0.35566522 |
| 128 | DYRK1A | 0.34876087 |
| 129 | MAPK7 | 0.33761087 |
| 130 | EEF2K | 0.33615151 |
| 131 | PRKCG | 0.32588332 |
| 132 | RPS6KA2 | 0.32562492 |
| 133 | ROCK2 | 0.31850159 |
| 134 | EPHA3 | 0.31083526 |
| 135 | JAK1 | 0.30989682 |
| 136 | MAP2K1 | 0.30976867 |
| 137 | RPS6KA3 | 0.30329985 |
| 138 | STK11 | 0.27564319 |
| 139 | LATS1 | 0.25347287 |
| 140 | PRKCE | 0.23845121 |
| 141 | MAP3K11 | 0.23774999 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.83427015 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.53948038 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.47375709 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.30282764 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.20117740 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.89588166 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.81954279 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.54893935 |
| 9 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.54690712 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.33332275 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.22312078 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.13989230 |
| 13 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.10237724 |
| 14 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.08967215 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.99332805 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.94328412 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.90277734 |
| 18 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.80709760 |
| 19 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.80472761 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.69503560 |
| 21 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.69005728 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.59412462 |
| 23 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.56630252 |
| 24 | Long-term potentiation_Homo sapiens_hsa04720 | 1.54834752 |
| 25 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.53421885 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.49973277 |
| 27 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.43634501 |
| 28 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.40788998 |
| 29 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.40489317 |
| 30 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.39912374 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.34124263 |
| 32 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.33380825 |
| 33 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.32448738 |
| 34 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.31256157 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.26728563 |
| 36 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.22614352 |
| 37 | Nicotine addiction_Homo sapiens_hsa05033 | 1.21361227 |
| 38 | Cocaine addiction_Homo sapiens_hsa05030 | 1.16162696 |
| 39 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.11500314 |
| 40 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.08951161 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.06239148 |
| 42 | Parkinsons disease_Homo sapiens_hsa05012 | 1.04665023 |
| 43 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.04013218 |
| 44 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.03268035 |
| 45 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.02236863 |
| 46 | Morphine addiction_Homo sapiens_hsa05032 | 0.99499575 |
| 47 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.99339302 |
| 48 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.95731639 |
| 49 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.95577336 |
| 50 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.94465756 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94356287 |
| 52 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.92852972 |
| 53 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.87816840 |
| 54 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.87137679 |
| 55 | Lysine degradation_Homo sapiens_hsa00310 | 0.86595744 |
| 56 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.86118376 |
| 57 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.84458066 |
| 58 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.84447757 |
| 59 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.84266975 |
| 60 | Insulin resistance_Homo sapiens_hsa04931 | 0.82905504 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.82259824 |
| 62 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.82220088 |
| 63 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.82057385 |
| 64 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.81949844 |
| 65 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.81068277 |
| 66 | Alzheimers disease_Homo sapiens_hsa05010 | 0.81047376 |
| 67 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.81036480 |
| 68 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.80336704 |
| 69 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.75886341 |
| 70 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.75003692 |
| 71 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.74053704 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.73616699 |
| 73 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.71823904 |
| 74 | Gap junction_Homo sapiens_hsa04540 | 0.68163912 |
| 75 | Histidine metabolism_Homo sapiens_hsa00340 | 0.66532108 |
| 76 | ABC transporters_Homo sapiens_hsa02010 | 0.65656729 |
| 77 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.65317766 |
| 78 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.61744026 |
| 79 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.60342896 |
| 80 | Galactose metabolism_Homo sapiens_hsa00052 | 0.58590010 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.56766719 |
| 82 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.55991230 |
| 83 | Melanogenesis_Homo sapiens_hsa04916 | 0.55798684 |
| 84 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54598151 |
| 85 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.53519070 |
| 86 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.53473596 |
| 87 | Prion diseases_Homo sapiens_hsa05020 | 0.51446366 |
| 88 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.50882443 |
| 89 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.49305538 |
| 90 | Tight junction_Homo sapiens_hsa04530 | 0.48288801 |
| 91 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.48081847 |
| 92 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.47850624 |
| 93 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.47834420 |
| 94 | Retinol metabolism_Homo sapiens_hsa00830 | 0.47105789 |
| 95 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.46890724 |
| 96 | Long-term depression_Homo sapiens_hsa04730 | 0.43680589 |
| 97 | Insulin secretion_Homo sapiens_hsa04911 | 0.43589275 |
| 98 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.42332647 |
| 99 | Huntingtons disease_Homo sapiens_hsa05016 | 0.42066785 |
| 100 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41306919 |
| 101 | Sulfur relay system_Homo sapiens_hsa04122 | 0.40859489 |
| 102 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.40090679 |
| 103 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.39838304 |
| 104 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.38461714 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36522156 |
| 106 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36123956 |
| 107 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.35481420 |
| 108 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.34397093 |
| 109 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.33600178 |
| 110 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.32877060 |
| 111 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.32472399 |
| 112 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31889145 |
| 113 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.31757667 |
| 114 | Circadian rhythm_Homo sapiens_hsa04710 | 0.31369050 |
| 115 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.30945303 |
| 116 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.30784561 |
| 117 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.27981601 |
| 118 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.27127006 |
| 119 | Renin secretion_Homo sapiens_hsa04924 | 0.26967679 |
| 120 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.25980807 |
| 121 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.25305123 |
| 122 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.24765944 |
| 123 | Circadian entrainment_Homo sapiens_hsa04713 | 0.24153930 |
| 124 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.22582504 |
| 125 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.22529928 |
| 126 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.22231949 |
| 127 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21878005 |
| 128 | Salivary secretion_Homo sapiens_hsa04970 | 0.21828249 |
| 129 | GABAergic synapse_Homo sapiens_hsa04727 | 0.21703637 |

